Literature DB >> 24399803

Longitudinal absolute metabolite quantification of white and gray matter regions in healthy controls using proton MR spectroscopic imaging.

Oliver T Wiebenga1, Antoine M Klauser, Gijsbert J A Nagtegaal, Menno M Schoonheim, Frederik Barkhof, Jeroen J G Geurts, Petra J W Pouwels.   

Abstract

The purpose of this study was to evaluate quality parameters, metabolite concentrations and concentration ratios, and to investigate the reproducibility of quantitative proton magnetic resonance spectroscopic imaging ((1)H-MRSI) of selected white and gray matter regions of healthy adults. 2D-quantitative short-TE (1)H-MRSI spectra were obtained at 1.5T from the healthy human brain. Subjects (n = 12) were scanned twice with an interval of six months. Absolute metabolite concentrations were obtained based on coil loading, taking into account differences in sensitivity of the phased-array head coil. Spectral quality parameters, absolute metabolite concentrations, concentration ratios, and their reproducibility were determined and compared between time-points using a repeated measures general linear model. The quality of the spectra of selected brain areas was good, as determined by a mean spectral linewidth between 4.8 and 7.3 Hz (depending on the region). No significant differences between the two time-points were observed for spectral quality, concentrations, or concentration ratios. The mean intrasubject coefficient of variation (CoV) varied between 4.0 and 8.5% for total N-acetylaspartate, 7.2 and 10.8% for total creatine, 5.9 and 9.8% for myo-inositol, and 8.0 and 13.3% for choline, and remained below 20% for glutamate. CoV was generally lower when concentration ratios were considered. The study shows that longitudinal quantitative short-TE (1)H-MRSI generates reproducible absolute metabolite concentrations in healthy human white and gray matter. This may serve as a background for longitudinal clinical studies in adult patients.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  MRSI; chemical shift imaging; gray matter; healthy controls; metabolites; reproducibility; spectroscopy; white matter

Mesh:

Substances:

Year:  2014        PMID: 24399803     DOI: 10.1002/nbm.3063

Source DB:  PubMed          Journal:  NMR Biomed        ISSN: 0952-3480            Impact factor:   4.044


  10 in total

1.  Enhanced axonal metabolism during early natalizumab treatment in relapsing-remitting multiple sclerosis.

Authors:  O T Wiebenga; A M Klauser; M M Schoonheim; G J A Nagtegaal; M D Steenwijk; J A van Rossum; C H Polman; F Barkhof; P J W Pouwels; J J G Geurts
Journal:  AJNR Am J Neuroradiol       Date:  2015-03-05       Impact factor: 3.825

2.  Changes of brain metabolite concentrations during maturation in different brain regions measured by chemical shift imaging.

Authors:  Eva Bültmann; Thomas Nägele; Heinrich Lanfermann; Uwe Klose
Journal:  Neuroradiology       Date:  2016-11-26       Impact factor: 2.804

3.  Longitudinal cerebral metabolic changes in pig-tailed macaques infected with the neurovirulent virus SIVsmmFGb.

Authors:  Chun-Xia Li; Xiaodong Zhang; Amelia Komery; Yingxia Li; Hui Mao; James G Herndon; Francis J Novembre
Journal:  J Neurovirol       Date:  2014-11-07       Impact factor: 2.643

4.  In vivo (1)H MRSI of glycine in brain tumors at 3T.

Authors:  Sandeep K Ganji; Elizabeth A Maher; Changho Choi
Journal:  Magn Reson Med       Date:  2015-02-04       Impact factor: 4.668

Review 5.  Metabolic and physiologic magnetic resonance imaging in distinguishing true progression from pseudoprogression in patients with glioblastoma.

Authors:  Sanjeev Chawla; Sultan Bukhari; Omar M Afridi; Sumei Wang; Santosh K Yadav; Hamed Akbari; Gaurav Verma; Kavindra Nath; Mohammad Haris; Stephen Bagley; Christos Davatzikos; Laurie A Loevner; Suyash Mohan
Journal:  NMR Biomed       Date:  2022-03-15       Impact factor: 4.478

6.  Fast 3D rosette spectroscopic imaging of neocortical abnormalities at 3 T: Assessment of spectral quality.

Authors:  Claudiu V Schirda; Tiejun Zhao; Victor E Yushmanov; Yoojin Lee; Gena R Ghearing; Frank S Lieberman; Ashok Panigrahy; Hoby P Hetherington; Jullie W Pan
Journal:  Magn Reson Med       Date:  2017-09-14       Impact factor: 4.668

7.  Reproducibility of brain metabolite concentration measurements in lesion free white matter at 1.5 T.

Authors:  Martin H J Busch; Wolfgang Vollmann; Serban Mateiescu; Manuel Stolze; Martin Deli; Marietta Garmer; Dietrich H W Grönemeyer
Journal:  BMC Med Imaging       Date:  2015-09-29       Impact factor: 1.930

8.  Reproducibility of quantitative structural and physiological MRI measurements.

Authors:  Stephen A McGuire; S Andrea Wijtenburg; Paul M Sherman; Laura M Rowland; Meghann Ryan; John H Sladky; Peter V Kochunov
Journal:  Brain Behav       Date:  2017-08-02       Impact factor: 2.708

9.  The Diagnostic Ability of Follow-Up Imaging Biomarkers after Treatment of Glioblastoma in the Temozolomide Era: Implications from Proton MR Spectroscopy and Apparent Diffusion Coefficient Mapping.

Authors:  Martin Bulik; Tomas Kazda; Pavel Slampa; Radim Jancalek
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

10.  Influence of macromolecule baseline on 1 H MR spectroscopic imaging reproducibility.

Authors:  Rebecca Birch; Andrew C Peet; Hamid Dehghani; Martin Wilson
Journal:  Magn Reson Med       Date:  2016-01-22       Impact factor: 4.668

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.